Workflow
员工持股计划
icon
Search documents
诺思格: 第四届监事会第十次会议决议公告
Zheng Quan Zhi Xing· 2025-09-05 16:22
Group 1 - The company held its 10th meeting of the 4th Supervisory Board on September 5, 2025, with all three supervisors present, complying with relevant laws and regulations [1] - The Supervisory Board approved the proposal for the 2025 Employee Stock Ownership Plan (ESOP), with a unanimous vote of 3 in favor [2] - The 2025 ESOP aims to enhance the company's governance structure, attract and retain talent, and align the interests of the core team with the company's long-term development goals [2][3] Group 2 - The management measures for the 2025 ESOP were also approved, ensuring the plan's smooth implementation and compliance with regulations [3] - The management measures are designed to create a balanced value distribution system, contributing to the company's sustainable development [3] - Both proposals will be submitted for approval at the company's upcoming shareholders' meeting [2][3]
弘元绿能: 2025年员工持股计划(草案)摘要
Zheng Quan Zhi Xing· 2025-09-05 16:22
证券代码:603185 证券简称:弘元绿能 债券代码:113642 债券简称:上 22 转债 弘元绿色能源股份有限公司 摘要 六、本员工持股计划中有关公司业绩考核指标的描述不代表公司的业绩预测, 亦不构成业绩承诺。 弘元绿色能源股份有限公司 二〇二五年九月 声明 弘元绿色能源股份有限公司及董事会全体成员保证本员工持股计划及其摘 要不存在虚假记载、误导性陈述或重大遗漏,并对其真实性、准确性、完整性承 担个别和连带的法律责任。 风险提示 一、公司 2025 年员工持股计划将在公司股东(大)会审议通过后方可实施, 本员工持股计划能否获得公司股东(大)会批准,存在不确定性。 二、有关本员工持股计划的具体资金来源、出资比例、实施方案等属初步结 果,能否完成实施,存在不确定性。 三、若员工认购资金较低,则本员工持股计划存在不能成立的风险;若员工 认购资金不足,本员工持股计划存在低于预计规模的风险。 四、本员工持股计划实施所产生的相关成本或费用的摊销可能对公司相关年 度净利润有所影响。 五、股票价格受公司经营业绩、宏观经济周期、国际/国内政治经济形势及 投资者心理等多种复杂因素影响。因此,股票交易是有一定风险的投资活动,投 ...
威派格: 威派格2025年第二次临时股东会会议资料
Zheng Quan Zhi Xing· 2025-09-05 16:13
Group 1 - The company is organizing a shareholder meeting on September 10, 2025, to discuss various proposals including the employee stock ownership plan [2] - The meeting will include the attendance of eligible shareholders, company directors, supervisors, senior management, and a witnessing lawyer [2] - The company plans to cancel the supervisory board and amend its articles of association, transferring the supervisory responsibilities to the audit committee of the board [1][3] Group 2 - The company proposes to implement the 2025 employee stock ownership plan to enhance the sharing of interests between employees and owners, improve governance, and boost employee morale [4] - The management measures for the 2025 employee stock ownership plan have been developed to ensure effective implementation [6] - The board seeks authorization from the shareholders to manage matters related to the 2025 employee stock ownership plan, including adjustments based on policy changes and qualification cancellations [6][7]
华兴源创: 华兴源创:关于股份回购实施结果暨股份变动的公告
Zheng Quan Zhi Xing· 2025-09-05 16:13
Core Viewpoint - The company has successfully completed a share repurchase plan, acquiring a total of 1,439,317 shares, which represents 0.32% of its total share capital, with the repurchase aimed at employee stock ownership plans or equity incentives [1][3][5]. Summary by Sections Share Repurchase Plan - The share repurchase plan was first disclosed on November 15, 2024, with an implementation period from November 14, 2024, to November 13, 2025 [1]. - The expected repurchase amount is between 40 million yuan and 80 million yuan, with a maximum repurchase price of 47.00 yuan per share [1][2]. - The board approved the plan on November 14, 2024, allowing the use of self-owned funds and a special loan from a bank for the repurchase [1][2]. Implementation Status - The company began its share repurchase on November 26, 2024, using a centralized bidding method [2][3]. - As of the announcement date, the total repurchased shares amounted to 1,439,317, with a total expenditure of approximately 40.29 million yuan [3][5]. - The highest repurchase price was 34.78 yuan per share, while the lowest was 22.66 yuan per share [3]. Shareholder Transactions - From January 20, 2025, to April 19, 2025, the actual controller of the company, Chen Wenyuan, increased his holdings by 887,093 shares, totaling approximately 26.51 million yuan [3][4]. Share Changes - Before the repurchase, the total number of shares was 442,828,931, which increased to 445,377,843 after the repurchase [4][5]. - The repurchased shares will be used for employee stock ownership plans or equity incentives and will not enjoy rights such as profit distribution or voting rights until utilized [5][6]. Future Plans for Repurchased Shares - The repurchased shares are to be used within three years from the announcement date; otherwise, the board will proceed with capital reduction procedures [5][6].
致欧科技发布2025年员工持股计划草案
Zheng Quan Ri Bao Wang· 2025-09-05 13:48
Core Viewpoint - Zhiou Technology (301376) announced a 2025 employee stock ownership plan aimed at enhancing employee engagement and company governance through shared interests [1] Group 1: Employee Stock Ownership Plan - The plan targets up to 46 individuals, including directors, supervisors, senior management, and key technical and business personnel [1] - The total number of shares to be transferred is capped at 1.2285 million shares, with a purchase price of 11.86 yuan per share, raising a maximum of 14.57 million yuan [1] Group 2: Objectives and Performance Assessment - The purpose of the plan is to establish a profit-sharing mechanism between employees and shareholders, improve governance, and boost employee morale and creativity [1] - The assessment period for the plan spans from 2025 to 2027, with performance metrics including company-level revenue growth rate or net profit growth rate [1]
弘元绿能拟推2025年员工持股计划
Ge Long Hui· 2025-09-05 12:31
本员工持股计划以"份"作为认购单位,1份额为1.00元,员工持股计划的总份数为不超过4,514.78万份。 本员工持股计划的参与对象所认购的具体份额根据实际出资缴款金额确定。资金来源为员工合法薪酬、 自筹资金和法律、行政法规允许的其他方式。本员工持股计划的最终参与人员和最终份额分配情况以实 际执行情况为准。 格隆汇9月5日丨弘元绿能(603185.SH)公布2025年员工持股计划,本员工持股计划规模不超过388.8698万 股,约占公司当前股本总额的0.57%。员工持股计划具体受让股份数量以实际执行情况为准确定。其 中,拟首次受让216.0207万股,占本员工持股计划标的股票总量的55.55%,占公司当前股本总额的 0.32%;预留172.8491万股,占本员工持股计划标的股票总量的44.45%,占公司当前股本总额的0.25%。 ...
开立医疗: 董事会薪酬与考核委员会关于公司 2025 年员工持股计划相关事项的核查意见
Zheng Quan Zhi Xing· 2025-09-05 12:20
Core Viewpoint - The company has conducted a thorough review of its 2025 Employee Stock Ownership Plan (ESOP) and has determined that it complies with relevant laws and regulations, aiming to enhance employee engagement and long-term value for shareholders [1][2]. Summary by Sections Legal Compliance - The company confirms that there are no prohibitive circumstances under the relevant laws and regulations for implementing the ESOP [1]. - The procedures for drafting the 2025 ESOP and related documents are legal and effective, adhering to the guidelines set forth in the relevant regulatory documents [2]. Employee Engagement - The ESOP has been developed with full consultation from employee representatives, ensuring that the decision-making process is legitimate and does not harm the interests of the company or its shareholders [2]. - Participation in the ESOP is voluntary, with no coercive measures employed to compel employees to join [2]. Benefits of the ESOP - The implementation of the ESOP is expected to foster a mechanism for sharing achievements and risks between talented employees and shareholders, enhancing employee ownership mentality [2]. - The plan aims to optimize the compensation structure and effectively allocate short, medium, and long-term incentive resources to attract, retain, and motivate outstanding talent, thereby promoting the company's long-term stability and increasing shareholder value [2].
开立医疗: 第四届董事会第十次会议决议公告
Zheng Quan Zhi Xing· 2025-09-05 12:20
Group 1 - The company held its 10th meeting of the 4th Board of Directors on August 29, 2025, with all 7 directors present, meeting the legal requirements [1][2] - The Board approved the draft of the 2025 Employee Stock Ownership Plan (ESOP) to enhance talent retention and align employee interests with shareholder value [2][3] - The voting result for the ESOP was unanimous, with 6 votes in favor and no opposition, representing 100% of the votes cast [3][4] Group 2 - The company plans to implement a 2025 Restricted Stock and Stock Option Incentive Plan to attract and retain talent while ensuring alignment of interests among shareholders, the company, and employees [5][6] - The voting result for the incentive plan was also unanimous, with 6 votes in favor and no opposition, representing 100% of the votes cast [6][7] - The Board proposed to authorize the shareholders' meeting to grant the Board the authority to manage the implementation of the incentive plan, including adjustments based on policy changes [7][8] Group 3 - The company will submit the ESOP and the incentive plan for approval at the upcoming shareholders' meeting [3][4] - The Board will also seek authorization to handle necessary administrative tasks related to the incentive plan, including approvals and registrations with relevant authorities [8][9] - The company aims to ensure the effective implementation of both plans to support its long-term development strategy [5][6]
开立医疗: 监事会关于公司 2025 年员工持股计划相关事项的核查意见
Zheng Quan Zhi Xing· 2025-09-05 12:20
Core Viewpoint - The Supervisory Board of Shenzhen Kaili Biomedical Technology Co., Ltd. has reviewed the 2025 Employee Stock Ownership Plan and concluded that it complies with relevant laws and regulations, and will not harm the interests of the company or its shareholders [1][2]. Summary by Sections Compliance and Legality - The company does not fall under any prohibitive conditions for implementing the employee stock ownership plan as per the relevant guidelines and regulations [1]. - The procedures for drafting the 2025 Employee Stock Ownership Plan and related documents are legal and effective [2]. Employee Involvement - The plan has been developed with sufficient consultation from employee representatives, ensuring that the decision-making process is legal and does not harm the interests of the company or its shareholders [2]. Eligibility and Benefits - The proposed participants in the employee stock ownership plan meet the eligibility criteria set forth in the relevant guidelines and regulations [2]. - Implementing this plan is expected to foster a mechanism for sharing achievements and risks between talented employees and shareholders, enhancing employee engagement, optimizing compensation structures, and promoting long-term stable development and shareholder value [2].
开立医疗: 第四届监事会第九次会议决议公告
Zheng Quan Zhi Xing· 2025-09-05 12:20
Group 1 - The company held the ninth meeting of the fourth supervisory board, which was legally valid with all three supervisors present [1] - The supervisory board unanimously approved the 2025 Employee Stock Ownership Plan, confirming its compliance with relevant laws and regulations [2][3] - The board believes that the employee stock ownership plan will enhance corporate governance and create a balanced value distribution system, benefiting the company's sustainable development [2][3] Group 2 - The supervisory board also approved the 2025 Restricted Stock and Stock Option Incentive Plan, which aligns with legal requirements and aims to attract and retain talent [3][4] - The plan is designed to integrate the interests of shareholders, the company, and employees, promoting long-term development without harming the interests of the company and its shareholders [3][4] - The board confirmed that there are no prohibitive circumstances for implementing the incentive plan, and the company is qualified to proceed [3][4] Group 3 - The 2025 Incentive Plan Management Measures were approved to ensure the plan's smooth implementation and compliance with legal standards [4] - The assessment indicators for the incentive plan are deemed scientific and reasonable, aimed at achieving the plan's objectives and enhancing corporate governance [4] - The board will publicly disclose the list of incentive plan participants before the shareholders' meeting, ensuring transparency [6]